TLPH Talphera, Inc.

NASDAQ
$0.86

Talphera, Inc. (TLPH) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.0% since its last earnings release on November 12, 2026.

Talphera, Inc. Beat Consensus Estimates
Thursday, November 12, 2026 · 4:01 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.08)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.90

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.